Pfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to 11.
Pfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to 11.
Elementary school-aged children already received kid-sized doses of Pfizer’s original vaccine, a third of the dose given to everyone 12 and older -- two primary shots plus a booster.If the Food and Drug Administration agrees, they would start getting a kid-sized dose of the new omicron-targeted formula when it was time for their booster.
FDA vaccine chief Dr. Peter Marks said last week he expected a decision on boosters for that age group soon.Pfizer and its partner BioNTech also announced a new study of the omicron-focused booster in even younger children, those ages 6 months through 4 years, to test different doses. Updated boosters made by both Pfizer and rival Moderna rolled out earlier this month for everyone 12 and older. They’re a tweak to vaccines that already have saved millions of lives -- a combination or “bivalent” shot that contains half the original recipe and half protection against the BA.4 and BA.5 omicron relatives responsible for most of today’s COVID-19 cases.
The hope is that the modified boosters will help tamp down continuing COVID-19 cases and blunt another winter surge. As of last week, the Centers for Disease Control and Prevention said 4.4 million Americans had gotten an updated booster so far.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer CEO tests positive for COVID for a second timeAlbert Bourla had contacted the virus in August and took a course of the company's oral COVID-19 antiviral treatment, Paxlovid. He said he has not yet taken the new bivalent booster.
Lire la suite »
Pfizer CEO tests positive for COVID-19 for second time in two monthsPfizer CEO Albert Bourla announced Saturday that he tested positive for COVID-19 — again.
Lire la suite »
Pfizer Requests Clearance for Children’s Covid-19 BoosterPfizer and BioNTech asked U.S. health regulators to clear use of their updated Covid-19 booster in children 5 years to 11 years, just as retooled shots for people 12 and older roll out.
Lire la suite »
Pfizer Asks FDA to Authorize Omicron Covid Booster Shots for Kids Ages 5 to 11Pfizer’s application to the FDA comes before clinical trial results of the omicron BA.5 booster shots have been published.
Lire la suite »
Pfizer submits application for updated COVID boosters for kids 5-11Both of the shots are bivalent, targeting the original 2019 strain as well as BA.4 and BA.5, which today account for 96% of new COVID-19 infections in the United States.
Lire la suite »
Pfizer seeks to expand omicron COVID booster to 5- to 11-year-oldsPfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to 11.
Lire la suite »